Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Follistatin is a critical mediator for FLT3/ITD+ acute myeloid leukemia Proceeding/Conference:Experimental Hematology | 2016 | ||
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia Journal:EMBO Molecular Medicine | 2020 | ||
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia Journal:Science Translational Medicine | 2016 | ||
| 2016 | |||
| 27-May-2022 | |||
| 2015 |
